CLINICAL_TRIALS
trial_result
· 2015-01-16
Clinical Trial Update: A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) [Phase 3]
Summary
A completed Phase 3 trial (AWARD-2) in participants with Type 2 diabetes mellitus has posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-01-16